Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer

Walter Jentzen, Robert F. Hobbs, Alexander Stahl, Jochen Knust, George Sgouros, Andreas Bockisch

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pre-therapeutic <sup>124</sup>I PET(/CT) dosimetry confirms low average absorbed doses per administered <sup>131</sup>I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences